Australian-based medicinal cannabis company Cannim has completed the first legal commercial export of Jamaican cannabis flower to Germany.
Chief commercial officer Stuart Marsh said the move was a key step in achieving Cannim’s mission to become a global leader in the medicinal and wellness cannabis sectors.
“Germany represents a huge opportunity for Cannim, and our ability to cultivate high quality, medical-grade Jamaican cannabis that meets strict German standards is testament to the professionalism of our teams in Jamaica and Australia.”
He added: “The support we have received from all levels of the Jamaican government and its agencies and the rigour of [the country’s] Cannabis Licensing Authority in ensuring [its] industry complies with international treaty obligations have been essential in securing Jamaica’s entry to this global arena.”
Jamaican minister of industry, investment and commerce Audley Shaw said: “Jamaica has long had a rich history with cannabis and we are proud to have been able to support the industry and Cannim in achieving this pioneering export to Germany.”
“We are excited to finally be able to start satisfying global demand for the finest Jamaican-grown medicinal cannabis products.”
The initial shipment of high-THC cannabis flowers was grown on Cannim’s 500-acre farm in Jamaica, representing the first batch of an ongoing supply, with significant quantities of the product ready to be released into Germany over the coming months.
Cannim will use Cantourage’s Fast Track Access platform to enter European medical markets.
Cantourage CEO Philip Schetter said: “This is an exciting milestone for the rapidly expanding medicinal cannabis sector in Germany. The local market has been growing for some time, but this is the first time we have been able to supply the highest quality products processed from genuine Jamaican cannabis flower.
“It is an important step in the development of this still nascent industry.”
